| Before treatment | 6 months after treatment | Relapse rate% | |||||
---|---|---|---|---|---|---|---|---|
Group | Dog | Clinical signs | Endoscopic changes | Histopathological changes | Clinical signs | Endoscopic changes | Histopathological changes | |
1 | A | +++ | +++ | ++ | + | + | ++ | (12,5/25) 50 |
B | ++ | ++ | + | + | + | + | ||
C | + | + | + | – | + | + | ||
D | + | + | + | +/− | – | – | ||
E | ++ | ++ | ++ | + | + | + | ||
Total | 25 | 12,5 | ||||||
2 | A | +++ | +++ | +++ | – | – | – | (0/29) 0 |
B | ++ | + | + | – | – | – | ||
C | ++ | ++ | ++ | – | – | – | ||
D | + | + | ++ | – | – | – | ||
E | ++ | + | ++ | – | – | – | ||
Total | 29 | 0 | ||||||
3 | A | +++ | +++ | +++ | ++ | ++ | +++ | (22/29) 75 |
B | ++ | ++ | ++ | + | + | ++ | ||
C | ++ | ++ | ++ | + | + | ++ | ||
D | + | + | ++ | + | + | + | ||
E | + | ++ | + | + | + | ++ | ||
Total | 29 | 22 |